UNIVERSAL TECHNICAL INSTITUTE, INC (UTI): what the price assumes

In the published model solve dated 2026-Q2, anchored at $42.26, UNIVERSAL TECHNICAL INSTITUTE, INC (UTI) is priced for today's economics sustained for ~7.5 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/UTI

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 7: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 8.4% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.1 years.

How unusual the bet is: high

Valuation X-Ray

Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that call it expensive: Asset, Earnings, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.2%); the inversion above states its own rate.

Per-Model Detail (n=8)

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

Bullet Takeaways

• Universal Technical Institute has evolved from a single-vertical automotive-tech school into a two-division career-education company, pairing the UTI division with Concorde Career Colleges in healthcare, which grew revenue 7.5% in Q2 fiscal 2026.
• Enrollment momentum is the headline: total new student starts rose 13.8% to 7,569 in Q2, with the company absorbing about $11 million of strategic growth expenses that temporarily pushed net income down to $0.4 million.
• The defining risk is regulatory: for-profit education depends on Title IV federal student aid, and rule changes on gainful employment, aid eligibility, or cohort default rates can hit revenue directly regardless of how the schools perform.

Bull Case

Frame Universal Technical Institute by its stage and the numbers read as deliberate investment, not weakness. This is a company in transition from a mature, single-vertical automotive-training school into a growing, two-division career-education platform, and a company in that phase spends ahead of its earnings on purpose. Q2 fiscal 2026 revenue rose 6.7% to $221.4 million, split between the UTI division at $142.7 million, up 6.3%, and the Concorde healthcare division at $78.7 million, up 7.5%. The Concorde acquisition diversified the company away from a single trade and into healthcare education, a structurally larger and more durable demand pool, which is the strategic reason the two-division structure exists.

The enrollment trend is the leading indicator that matters, and it is strong. Total new student starts grew 13.8% to 7,569, with the UTI division up roughly 15% and Concorde up 13%, while average full-time active students rose 7.2% to 26,385. In an education business, new starts today are revenue over the coming quarters as those students progress through their programs, so double-digit start growth is a forward signal that the revenue base is set to keep expanding. The company also has 20 new program launches in its pipeline and reported better-than-modeled initial performance at new campuses, which is the expansion engine feeding the start growth.

The earnings depression is explained, which is the key to reading the stage correctly. Q2 net income fell to $0.4 million, but the company absorbed about $11 million of strategic growth expenses; baseline adjusted EBITDA was $25.1 million before those investments versus the $14.1 million reported. That is a company choosing to spend on new campuses and programs now for higher enrollment later, and it reaffirmed its full-year guidance while projecting the fourth quarter as its strongest. With net cash on the balance sheet and interest coverage near 13 times, it can fund the expansion internally. The bull case is a career-education platform in its growth-investment phase, with double-digit enrollment growth and a diversified two-division model, where the depressed current earnings are the investment, not the result.

Bear Case

The external variable with the most leverage on Universal Technical Institute is regulation, and it is the kind of risk that no amount of operational excellence can hedge. For-profit education runs on Title IV federal student aid, which funds the large majority of student tuition across the industry. That makes the company hostage to the rules governing aid eligibility, gainful-employment standards, cohort default rates, and the broader political posture toward for-profit schools. A tightening of those rules, a change in aid availability, or an adverse finding can cut revenue directly, independent of how well the campuses run or how many students enroll. The sector has lived through cycles of regulatory crackdown before, and a company expanding aggressively into new programs is adding exposure to that rulebook, not reducing it.

The valuation gives no cushion for that risk. On trailing earnings depressed by growth spending, no valuation family reaches the price: the asset and earnings-power methods land far below, with the simple excess-return method near $8 against a book value of $6.10 a share and normalized earnings power near $2, because there is little current operating profit to capitalize. Even the relative-multiple and forward-growth methods sit below the price, in the low-to-mid $20s. The price is paying for the enrollment growth to convert into a much higher earnings base over years, and it is paying a premium to every standard method to do so. If the conversion stalls, or regulation clips the aid that funds it, the price has no value-method floor nearby.

The dilution is the second concern. The share count has grown about 13.6% as the company financed its expansion and the Concorde acquisition, so per-share earnings have to clear that dilution before holders benefit from the growth. Growth funded by issuing shares only pays off if the new capital earns more than it dilutes, and the current depressed earnings make that case unproven for now. The balance sheet is sound, with net cash and healthy interest coverage, so the bear is not about solvency. It is that a for-profit educator priced for years of enrollment-driven earnings growth sits on top of a federal-aid dependency that can change with the political weather, while diluting holders to fund the very expansion the price is betting on.

Valuation

The price is making a growth-conversion bet on a business whose current earnings are deliberately suppressed. Inverting today's price near $40 (June 28, 2026) implies operating compounding sustained for about eight years on an operating margin near 2.7%, below the 6.3% the company earns on trailing numbers and far below what a scaled education platform can earn. The embedded assumption is that the enrollment growth converts into a materially larger and more profitable business over time, which is plausible given the start trends but is a multi-year bet, not a current fact.

The methods all land below the price, which is the signature of a growth-investment story priced for the payoff. The asset-based methods land near $8 to $10 against a thin book value, and the earnings-power methods land near $2 to $8 because they capitalize the depressed current earnings with no growth, which understates a business spending heavily to expand. The relative-multiple and forward-growth methods land higher, in the low-to-mid $20s, with the exit-multiple cash-flow method near $27 and the sector price-to-earnings approach near $23, but still below the price. So no family reaches the current level; the price is a bet beyond what the standard methods support, defended by the enrollment momentum and the expectation that today's growth spending produces tomorrow's margin. That is a coherent thesis, but it is an extrapolation, and the methods correctly flag that the price has run ahead of the demonstrated economics.

The balance sheet bounds the downside and funds the bet. The company holds net cash of about $28 million with interest coverage near 13 times, so it can self-fund its campus and program expansion without distress, though it has leaned on share issuance, lifting the count about 13.6%. The relevant peer comparison is the small set of publicly traded post-secondary education companies, where the question is enrollment growth, regulatory standing, and the ability to convert starts into durable revenue. What the buyer is underwriting at this price is that the double-digit enrollment growth converts into a much higher earnings base over the next several years, on a business whose revenue rests on federal student aid and whose share count has been growing to fund the expansion.

Catalysts

The Q2 fiscal 2026 report was the catalyst, and it showed strong enrollment against depressed near-term profit. Revenue rose 6.7% to $221.4 million, with the UTI division up 6.3% to $142.7 million and the Concorde healthcare division up 7.5% to $78.7 million. Net income fell to $0.4 million because the company absorbed about $11 million of strategic growth expenses; baseline adjusted EBITDA was $25.1 million before those investments, versus $14.1 million reported.

The enrollment and expansion metrics are the forward catalysts. Total new student starts rose 13.8% to 7,569, with the UTI division up about 15% and Concorde up 13%, and average full-time active students rose 7.2% to 26,385. Management highlighted 20 new program launches in the pipeline and better-than-modeled performance at new sites, reaffirmed full-year guidance, and projected the fourth quarter as the strongest for revenue and profitability.

The catalysts to watch are the quarterly new-student-start and active-student trends, which lead revenue, the pace at which the strategic growth spending rolls off and margins recover toward the baseline, and the fourth-quarter result management has flagged as the year's strongest. The regulatory backdrop, particularly any developments on Title IV aid rules and gainful-employment standards, is the macro variable with the most leverage on the thesis, since it governs the funding behind the enrollment the price is paying for.

Peer Cohorts (Per Segment, With Filing Citations)

UTI (reported)

• LAUR (Laureate Education, Inc.)
• FY2025 10-K: …4 Country Institution Enrollment at December 31, 2025 Market Segment QS Stars™ Overall University Rating Ratings/Rankings Mexico Universidad del Valle de México (UVM) 132,200 Premium/ Traditional «««« • Ranked Top 5 university in Mexico • 5-Star rated by QS Stars™ in categories of Employability, Online Learning &…
• FY2025 10-K: …We expect competition to increase as the Mexican and Peruvian markets mature. Essentially all of our revenues were generated from private pay sources as there are no material government-sponsored loan programs in Mexico or Peru. Specifics related to both of our reportable segments are discussed below: • Private…
• CVSA (Covista Inc.)
• FY2025 10-K: …are eligible to do clinical rotations at AUC's clinical sites, which include hospitals in the U.S., Canada, and the U.K. This program is aimed at preparing students for USMLEs. Medical Education Readiness Program ("MERP") is a 15-week medical school preparatory program focused on enhancing the academic foundation of…
• FY2025 10-K: …BS in Elementary Education and Master of Arts in Teaching with a specialization in Special Education, and advanced educator preparation programs, education specialist in Educational Leadership and Administration and MS in Education with a specialization in Educational Leadership and Administration, in the Richard W.…
• STRA (Strategic Education, Inc.)
• FY2025 10-K: …state. The universities may not enroll a student 23 Table of Contents for Title IV purposes in a state in which the program does not meet such requirements unless at the time of initial enrollment the student attests their intent to seek employment in another state in which the program would satisfy such…
• FY2025 10-K: …as Chairman of the Board. He previously served as Executive Chairman of the Board from 2013 to 2023 and as Chairman of the Board from February 2003 to 2013. He was the Company's Chief Executive Officer from March 2001 to 2013. From 1995 to 2000, Mr. Silberman served in a variety of senior management positions at…
• GHC (GRAHAM HOLDINGS CO)
• FY2025 10-K: …violates the First Amendment. The Company cannot predict how GMG's stations may be affected by the FCC's current or future interpretation and enforcement of its indecency policies. HEALTHCARE The healthcare group provides home health infusions through its CSI Pharmacy Holding Company, LLC (CSI) segment and other…
• FY2025 10-K: …Participation in these services has given the Company's stations access to new distribution platforms. At the same time, competition from these various platforms could adversely affect the viewership of the Company's television stations via traditional platforms and/or the Company's strategic position in negotiations…
• LOPE (Grand Canyon Education, Inc.)
• FY2025 10-K: …sales terms, adapt more quickly to new technologies and changes in university partner and student requirements, and devote greater resources to the acquisition of qualified students than we can; and ● c urrent and potential competitors may establish cooperative relationships among themselves or with third parties to…
• FY2025 10-K: …in the post-secondary education sector; ● competitors with lower p riced programs; ● a decline in the overall growth of enrollment in post-secondary institutions; ● a decrease in or perceived low student passage rates for professional licenses and other examinations necessary for students to work in their chosen…
• PRDO (Perdoceo Education Corporation)
• FY2025 10-K: …of operating results for AIUS will primarily focus on AIU and Trident, which represent a majority of the AIU System and AIUS reporting segment. Specific references will be made to the other universities when material to the disclosure or necessary to understand the overall discussion. USAHS USAHS is dedicated to…
• FY2025 10-K: …revenue into 2026. The slight decrease in revenue is driven by Trident University, as the recent government shutdown disparately impacted this institution. Current year operating income for AIUS increased by 9.8% or $3.2 million as compared to the prior year, driven by lower operating expenses as compared to the…
• LRN (Stride, Inc.)
• FY2025 10-K: …as well as registration requirements under state consumer finance laws. Lastly, additional regulations and student outcome reporting requirements may affect Galvanize, Tech Elevator and MedCerts should they seek funding related to the Workforce Innovation and Opportunity Act in any given state. Federal Laws…
• FY2025 10-K: …to provide our services and solutions, we depend on various computer systems, hardware, software, infrastructure, online sites and connected networks (hereinafter, "IT Systems"), including those of third parties. In addition, as part of our business, we collect, use, process, transmit, host and store information,…

Concorde (reported)

• CVSA (Covista Inc.)
• FY2025 10-K: ​ ​ 136,777 ​ ​ ​ ​ ​ ​ 136,777 Stock-based compensation ​ ​ ​ ​ 25,947 ​ ​ ​ ​ ​ ​ ​ ​ 25,947 Net activity from stock-based compensation awards 962 ​ 10 ​ 17,078 ​ ​ ​ ​ 165 ​ ( 7,731 ) ​ 9,357 Proceeds from stock issued under Colleague Stock Purchase Plan ​ ​ ​ ​ 163 ​ ( 18 ) ​ ​ ( 20 ) ​ 756 ​ 901 Repurchases of…
• FY2025 10-K: …Statements of Shareholders' Equity (in thousands) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Accumulated ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Additional ​ ​ ​ ​ Other ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Common Stock ​ Paid-In ​ Retained ​ Comprehensive ​ Treasury Stock ​ ​ ​ ​ ​ Shares ​ Amount ​ Capital ​…
• LAUR (Laureate Education, Inc.)
• FY2025 10-K: Cardoso and MC Consultoria and Assesoria Empresarial LTDA 10-K 001-38002 10.43 02/23/2023 10.35† Second Amendment to Independent Contractor and Consultant Agreement as of March 1, 2022 between Laureate Education, Inc. and MC Consultoria and Assesoria Empresarial LTDA 10-K 001-38002 10.44 02/23/2023 10.36† Third…
• FY2025 10-K: …Buskirk earned a B.S. in accounting from the University of Maryland and a dual M.B.A. from Columbia University and London Business School. Marcelo Barbalho Cardoso has served as our Executive Vice President and Chief Operating Officer since June 2021. Mr. Cardoso has been with Laureate since 2011, holding several…
• GHC (GRAHAM HOLDINGS CO)
• FY2025 10-K: …outstanding revolving loans under the existing revolving credit facility, and (iii) repay all amounts outstanding under the Company's existing $ 150 million term loan. At December 31, 2025, the fair value of the Company's $ 500 million of 5.625 % unsecured notes, based on quoted market prices (Level 2 fair value…
• FY2025 10-K: …Honda of Woodbridge in Virginia. The Company has a management services agreement with an entity affiliated with Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships, to operate and manage the operations of the dealerships. The Company also owns Roda, which provides valet automotive…
• STRA (Strategic Education, Inc.)
• FY2025 10-K: , 2025) . 21.1* Subsidiaries of Registrant. 23.1* Consent of PricewaterhouseCoopers LLP. 23.2* Consent of Deloitte & Touche LLP. 24.1* Power of Attorney (included in signature page hereto). 31.1* Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Act. 31.2* Certification of Chief…
• FY2025 10-K: …Inc., certain subsidiaries of Strategic Education, Inc. party thereto as subsidiary guarantors, and Truist Bank, as Administrative Agent (incorporated by reference to Exhibit 10.1 of the Company's Quarterly Report on Form 10-Q filed with the Commission on July 31, 2024). 10.7 Sixth Amendment to Second Amended and…
• PRDO (Perdoceo Education Corporation)
• FY2025 10-K: David C. Czeszewski William D. Hansen Senior Vice President and Chief Information Officer President and Chief Executive Officer of Building Hope Holdings, Inc. Greg E. Jansen Todd S. Nelson Senior Vice President, General Counsel and Corporate Secretary President and Chief Executive Officer of Perdoceo Education…
• FY2025 10-K: December 31, 2025 December 31, 2024 Cost Accumulated Amortization Accumulated Impairments Net Book Value Cost Accumulated Amortization Accumulated Impairments Net Book Value Amortizable intangible assets: Course curriculum $ 18,290 $ ( 6,571 ) $ - $ 11,719 $ 18,290 $ ( 2,418 ) $ - $ 15,872 Customer relationships…
• LOPE (Grand Canyon Education, Inc.)
• FY2025 10-K: Agreement, dated July 1, 2018, by and between Grand Canyon Education, Inc. and Grand Canyon University (formerly known as Gazelle University)# ​ Incorporated by reference to Exhibit 2.1 to GCE's Quarterly Report on Form 10-Q filed with the SEC on November 8, 2018. ​ ​ ​ ​ ​ 2.2 ​ Agreement and Plan of Merger, dated…
• FY2025 10-K: ACT OF 1934 ​ For the fiscal year ended: December 31, 2025 ​ OR ​ ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ​ For the transition period from [ ] to [ ] ​ Commission file number: 001-34211 GRAND CANYON EDUCATION, INC. (Exact name of registrant as specified in its…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.